# GPT 5.2 Review - Reviewer 3/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-29T19:02:59.079568
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_072fa45c05373b5d00697ba011ce008195868dc6496b23d715
**Tokens:** 19624 in / 5536 out
**Response SHA256:** d3c8b5cc978c7a85

---

## Referee Report (general-interest journal / AEJ: Economic Policy standard)

### Summary
The paper asks whether **recreational marijuana retail legalization affects entrepreneurship**, proxied by **Census BFS business applications per capita**, exploiting **staggered retail-market openings across 21 states (2014–2024)**. The headline finding is a **modest decline in applications (≈3–7%)** with mixed statistical significance; Callaway–Sant’Anna (CS) estimates are smaller and often insignificant; dynamics suggest effects emerge gradually post-opening. The paper also reports a **positive association for BF8Q formations**, appropriately warning that BF8Q is *not* causally interpretable under the design.

The question is interesting and policy-relevant, the data are high quality, and the author is clearly aware of modern DiD concerns. However, at a top journal bar, the paper is **not yet identification-credible or empirically decisive enough**, largely because (i) the analysis unnecessarily discards the BFS’s monthly timing variation, creating treatment-timing mismeasurement and low power; (ii) inference/presentation and pre-trend diagnostics are incomplete; and (iii) the state-level DiD design needs substantially stronger validation/triangulation (intensity, borders, sectoral composition, alternative outcomes).

---

# 1. FORMAT CHECK

**Length**
- The PDF appears to run **~34 pages total**, with **main text through p. 25** and references beginning around **p. 26** (then appendices). This likely **meets** the “≥25 pages excluding references/appendix” expectation *barely*, depending on what you count as appendix vs. main text. If aiming for AER/QJE/JPE/ReStud/Ecta, the *main* paper could still benefit from a more developed empirical/results section (not necessarily longer, but denser and more definitive).

**References**
- Bibliography includes key DiD papers (Callaway–Sant’Anna, Goodman-Bacon, Sun–Abraham, de Chaisemartin–D’Haultfœuille) and some domain references. But it is **thin** relative to the entrepreneurship/business-dynamism and “policy evaluation with staggered adoption” literatures. Missing items listed in Section 4 below.

**Prose vs bullets**
- Introduction and Results/Discussion are mostly paragraph-form (good).
- Conceptual framework includes several **bullet lists** (Section 3). Bullets are fine for mechanisms, but in a top journal the conceptual section should also include **paragraph narrative** linking mechanisms to *testable implications* and mapping to BFS series more explicitly.

**Section depth (3+ substantive paragraphs each)**
- **Introduction (Section 1):** yes (multiple paragraphs).
- **Institutional background (Section 2):** yes.
- **Conceptual framework (Section 3):** borderline—reads partly like notes (bullets) rather than a developed framework.
- **Data (Section 4):** yes.
- **Empirical strategy (Section 5):** yes.
- **Results (Section 6):** yes but should be expanded with clearer “main spec → threats → validation” structure.
- **Discussion (Section 7):** yes.

**Figures**
- Figures shown (e.g., trends; event study; coefficient plot; permutation histogram) have axes and visible data. Publication quality is **adequate**, but several are visually small/low-ink and would need journal-grade polishing (font sizes, line weights, clearer legends, and explicit units).

**Tables**
- Tables contain real numbers and SEs. Good.

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

### a) Standard Errors
- **PASS.** Regression tables report SEs in parentheses (e.g., Table 3; Table 5). CS estimates report SEs as well.

### b) Significance testing
- **PASS** in the narrow sense (t-stats/p-values implied; stars shown; randomization inference and bootstrap included).
- **But**: top journals expect more than “star-based” inference—see CI discussion.

### c) Confidence intervals (95% CIs)
- **Partial FAIL (presentation).** You provide a 95% CI for the CS overall ATT (Table 4 Panel A), and bootstrap CI is reported. However, **main regression tables (TWFE and series decomposition) do not report 95% CIs**, and the paper’s narrative often emphasizes marginal significance (10%) without consistently providing uncertainty bands.
- Fix: add 95% CIs to all key estimates (tables or inline), and make plots show 95% bands (some do).

### d) Sample sizes
- **PASS.** N is reported for key regressions (e.g., N=1,020; BF8Q N=623).

### e) DiD with staggered adoption
- **PASS (method choice), with caveats.**
  - You correctly acknowledge TWFE bias under heterogeneity and implement **Callaway–Sant’Anna** using never-treated controls.
  - However, you still place substantial interpretive weight on TWFE “benchmark” estimates. In a modern top-journal standard, TWFE should be clearly relegated to a robustness/legacy comparison; the *main* should be CS / Sun–Abraham / BJS-imputation style estimands with careful dynamic aggregation choices.

### f) RDD
- Not applicable (no RDD).

### Additional methodology concerns (important)
1. **Unnecessary annual aggregation (major issue).**  
   BFS is monthly; treatment (retail opening) is dated at least to month/day. Aggregating to annual:
   - introduces **treatment misclassification within the adoption year** (some states open mid-year; you code the whole year as treated);
   - attenuates dynamic effects and blurs anticipation/phase-in;
   - reduces power and complicates interpretation (“year 0” is not comparable across states).
   For top journals, you should estimate the core design at **monthly frequency** (state×month panel) with appropriate seasonality controls and modern DiD estimators.
2. **CS event-study inference is under-developed.**  
   You note you cannot run a joint pre-trend test due to a singular covariance matrix. This is a red flag: you need alternative approaches (drop far leads, collapse leads, use imputation estimators, or use “honest DiD” style sensitivity).
3. **Inference with 51 clusters is usually okay, but treatment is only 21 clusters;** you do randomization inference and cluster bootstrap (good), but you should also consider **wild cluster bootstrap** p-values for key coefficients and/or report randomization inference for the **CS estimand** (not only TWFE).

**Bottom line on methodology:** The paper is *not unpublishable* on inference grounds (you do inference and use heterogeneity-robust DiD), but it **does not yet meet top-journal standards of design-execution**, mainly due to annual aggregation and incomplete validation of parallel trends / dynamics.

---

# 3. IDENTIFICATION STRATEGY

### Credibility
- The basic idea—staggered retail openings—can be credible, but **state-level adoption of recreational cannabis is highly endogenous** to political, demographic, and economic trends. State FE absorb levels; year FE absorb national shocks; but the key risk is **differential evolving trends** correlated with adoption (e.g., migration, tech/finance cycles, housing booms, COVID-era entrepreneurial surge).
- Your event study shows no *statistically significant* pre-trends (Figure 2), but lack of significance is not strong evidence of parallel trends—especially with wide bands and annual timing.

### Key assumptions discussed?
- You discuss parallel trends and test via event study (good).
- But you do not provide enough evidence on:
  - **anticipation effects** (legalization date vs. retail opening; licensing ramp-up; firms forming in advance);
  - **treatment intensity heterogeneity** (local opt-outs; license caps; taxation; enforcement).

### Placebos / robustness
- Strengths:
  - randomization inference and bootstrap inference;
  - restricting control group to medical-only states;
  - dropping COVID years.
- Missing robustness/validation that a top journal would expect:
  1. **Alternative comparison groups**: e.g., “not-yet-treated” in CS (carefully), or matched controls, or synthetic control checks for early adopters.
  2. **Border-county design** (recommended): compare counties near borders across treated vs untreated states to reduce compositional differences and absorb region-specific shocks.
  3. **Intensity-based DiD**: use dispensary counts, licenses issued, sales per capita, or local opt-out shares. State “ever opened retail” is extremely coarse and likely mismeasured.
  4. **Negative-control outcomes**: show that outcomes that should not move (or move differently) do not respond similarly.
  5. **Alternative entrepreneurship measures**: BDS firm births, QCEW establishment counts, CBP changes, ADS/ABS entrepreneurship rates, patenting/new trademarks, etc. A single outcome series is fragile.

### Do conclusions follow?
- The paper is careful about BF8Q non-causality (good).
- However, the conclusion that legalization “modestly reduces business applications” is **overstated** given:
  - CS ATT is small and imprecise;
  - cohort heterogeneity includes positive estimates for later cohorts;
  - dynamics show large long-run negative point estimates but with wide uncertainty.
- A top-journal framing would be more conditional: “We do not find evidence of increased aggregate applications; if anything, point estimates suggest modest declines, concentrated among early adopters.”

### Limitations
- You list many limitations (COVID, local option, BF8Q timing) and this is a strength. But limitations should motivate **additional analyses** rather than remain as caveats.

---

# 4. LITERATURE (missing references + BibTeX)

### DiD / event study diagnostics and robustness (missing)
You cite the core staggered-adoption critique papers, which is good. What is missing are the now-standard tools for **pretrend sensitivity** and for **practical implementation choices**:

1) **Rambachan & Roth (Honest DiD / sensitivity to violations of parallel trends)**  
Why relevant: Your identifying variation is political and likely violates strict parallel trends. HonestDiD provides sensitivity intervals rather than binary pre-trend tests.

```bibtex
@article{RambachanRoth2023,
  author  = {Rambachan, Ashesh and Roth, Jonathan},
  title   = {A More Credible Approach to Parallel Trends},
  journal = {Review of Economic Studies},
  year    = {2023},
  volume  = {90},
  number  = {5},
  pages   = {2555--2591}
}
```

2) **Roth (pre-trends, power, and interpretation of event studies)**  
Why relevant: Your “no significant pre-trends” argument needs the caution emphasized in this literature.

```bibtex
@article{Roth2022,
  author  = {Roth, Jonathan},
  title   = {Pretest with Caution: Event-Study Estimates after Testing for Parallel Trends},
  journal = {American Economic Review: Insights},
  year    = {2022},
  volume  = {4},
  number  = {3},
  pages   = {305--322}
}
```

3) **Baker, Larcker & Wang (practical guidance / weighting pathologies in DiD)**  
Why relevant: Helps motivate estimator choice and interpret differences between TWFE and CS.

```bibtex
@article{BakerLarckerWang2022,
  author  = {Baker, Andrew C. and Larcker, David F. and Wang, Charles C. Y.},
  title   = {How Much Should We Trust Staggered Difference-in-Differences Estimates?},
  journal = {Journal of Financial Economics},
  year    = {2022},
  volume  = {144},
  number  = {2},
  pages   = {370--395}
}
```

4) **Gardner (two-stage DiD / did2s)**  
Why relevant: A transparent alternative to TWFE, often used as robustness.

```bibtex
@article{Gardner2022,
  author  = {Gardner, John},
  title   = {Two-Stage Difference-in-Differences},
  journal = {Journal of Econometrics},
  year    = {2022},
  volume  = {231},
  number  = {2},
  pages   = {1--20}
}
```

### Entrepreneurship / business dynamism measurement
You cite Decker et al. and Haltiwanger et al., but BFS-focused entrepreneurship work is broader. Consider:

5) **Davis et al. / business dynamism trend context** (or a modern JEP piece on dynamism)  
(You already have Decker et al. 2014; still, the dynamism decline literature is large—cite selectively.)

### Cannabis policy empirical literature (missing)
Your cannabis literature coverage is light relative to the size of the field; you cite a review and a few papers. At minimum add major economics evaluations of recreational legalization and market opening effects. Examples often cited in econ work include:

6) **Hansen, Miller & Weber (dispensary access / labor or crime contexts depending on paper)**  
(Exact bibliographic details vary by specific paper; you should add at least 1–2 “market opening / dispensary” causal papers beyond Nicholas & Maclean.)

Also, since your mechanism discussion emphasizes banking and 280E constraints, cite work on cannabis banking constraints if available in peer-reviewed outlets (or at least high-quality policy/econ working papers).

---

# 5. WRITING QUALITY (CRITICAL)

### a) Prose vs bullets
- **Mostly pass**, but Section 3 leans heavily on bullets. For a top journal, the conceptual framework should be more than a list: it should articulate *predictions* mapping to BA/HBA/WBA/CBA and to dynamics (short-run vs long-run).

### b) Narrative flow
- The introduction is competent and clearly states the question and approach (pp. 3–5).
- The narrative becomes more “technical report-like” in Sections 5–6: you list estimators and then report many coefficients, but you do not always **interpret magnitudes in economically meaningful units** (e.g., applications per 100k translated to counts for a median state).

### c) Sentence quality
- Generally clear, but sometimes repetitive (“modest decline,” “suggestive,” “cannot be interpreted causally”). Tighten by:
  - moving the key contribution and identifying variation earlier;
  - cutting hedging phrases where not necessary;
  - making each paragraph’s first sentence do more work.

### d) Accessibility
- Good job explaining why retail-opening timing matters.
- But the BF8Q critique, while correct, is long and could be made clearer with a small timing diagram and a crisp statement of the violated condition.

### e) Figures/tables
- Figures are serviceable but not yet top-journal polish (font sizes, clarity, consistent style).
- Tables should:
  - include **95% CIs** or at least an additional column with CI bounds for main specs;
  - clearly label the dependent variable unit (log per 100k vs log per capita).

---

# 6. CONSTRUCTIVE SUGGESTIONS (to make this publishable at a top outlet)

## A. Make the BFS frequency match the policy timing (highest priority)
1) **Re-estimate everything at monthly frequency** (state×month), using:
   - month/year FE (or month-of-year seasonality FE plus time FE),
   - CS (group-time ATTs) with treatment defined by **month of first retail sales**,
   - dynamic event studies in months relative to opening.
2) Address staggered timing with **multiple modern estimators**, not just CS:
   - Sun–Abraham interaction-weighted event study,
   - Borusyak–Jaravel–Spiess imputation estimator,
   - (optionally) de Chaisemartin–D’Haultfœuille DID\_M-type robustness.

This alone may change the results materially (and will certainly change precision).

## B. Strengthen identification beyond “state FE + year FE”
Top journals will ask: “Why are cannabis-adopting states a good counterfactual for non-adopting states?”

You should add at least one of:

1) **Border-county DiD** (very compelling here)  
Use county-level BFS? If unavailable, use county Business Patterns / QCEW establishment counts / BDS at finer geography. Compare counties near treated-state borders to neighboring counties across the border, absorbing region shocks with border-pair×time FE.

2) **Treatment intensity**  
Compile state-month measures: number of dispensaries, licenses issued, sales per capita, tax rates, local opt-out share. Replace the binary Treated with an intensity measure; or instrument intensity with statutory features (license caps / timing rules), if defensible.

3) **Synthetic control / augmented SCM for early adopters**  
Colorado/Washington are iconic. A credible SCM showing post-opening divergence in applications per capita would be persuasive and transparent.

## C. Clarify estimand and interpretation
- Be explicit: you estimate the effect of **opening legal retail sales** on **aggregate EIN applications** (not “entrepreneurship” in general).
- Discuss whether cannabis firm entry might occur via **existing firms** (not requiring new EINs), which could mechanically mute positive effects in BFS.
- Translate effect sizes: a −0.03 log point effect is ~3%. What is that in application counts for a typical state-year?

## D. Fix pre-trends diagnostics properly
- If the CS covariance is singular, do not stop there. Options:
  - collapse leads into bins (e.g., ≤−5, −4..−2, −1),
  - reduce the number of leads,
  - use alternative estimators with better-behaved variance,
  - implement **HonestDiD** sensitivity intervals.

## E. Re-think BF8Q usage
You are correct BF8Q is forward-looking and not clean in a simple DiD. Still, you can do better than “descriptive only”:

- Redefine the outcome as a **formation-year** measure (BDS births) or use payroll filings/CBP changes.
- Or define treatment at the **application-cohort level** so that the BF8Q window lies fully post- or pre-treatment (e.g., drop cohorts whose 8-quarter window straddles opening; use a “donut” around treatment).

## F. Explore heterogeneous effects that map to mechanisms
Mechanisms you discuss imply testable heterogeneity:
- banking access (share of local banks participating in cannabis banking compliance, or general bank density),
- regulatory strictness (license caps, equity program delays),
- tax rates,
- local opt-outs,
- early vs late adopters (you do this, but expand and pre-register dimensions).

---

# 7. OVERALL ASSESSMENT

### Key strengths
- Important and under-studied question: cannabis policy beyond the cannabis sector.
- High-quality national administrative data (BFS).
- Correct awareness of staggered-adoption pitfalls; CS estimator implemented.
- Thoughtful caveat on BF8Q non-causal interpretation.
- Extra inference via permutation and bootstrap is a plus.

### Critical weaknesses (top-journal blocking)
1. **Annual aggregation is a major design flaw** given the policy’s precise timing and BFS’s monthly frequency; it likely attenuates effects and muddles dynamics.
2. **Identification remains fragile** with state-level DiD given endogenous adoption; needs border/intensity/SCM triangulation.
3. **Pre-trend evidence is not yet persuasive**; inability to do joint tests is not resolved with alternatives.
4. **Contribution relative to Brown et al. (2023)** is plausible but not yet sharply demonstrated—especially since your main effects are small/insignificant and could reflect measurement (EIN applications vs establishment births).

---

DECISION: MAJOR REVISION